Empower Advisory Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$439K Sell
781
-559
-42% -$358K ﹤0.01% 345
2025
Q4
$907K Buy
1,340
+557
+71% +$379K ﹤0.01% 257
2025
Q3
$500K Buy
783
+7
+0.9% +$4.25K ﹤0.01% 345
2025
Q2
$416K Sell
776
-7
-0.9% -$3.35K ﹤0.01% 349
2025
Q1
$329K Buy
783
+1
+0.1% +$434 ﹤0.01% 385
2024
Q4
$323K Sell
782
-44
-5% -$19.3K ﹤0.01% 389
2024
Q3
$417K Sell
826
-3
-0.4% -$1.46K ﹤0.01% 347
2024
Q2
$404K Sell
829
-10
-1% -$5.02K ﹤0.01% 341
2024
Q1
$453K Sell
839
-7
-0.8% -$3.83K ﹤0.01% 318
2023
Q4
$470K Buy
846
+12
+1% +$5.63K ﹤0.01% 306
2023
Q3
$365K Hold
834
﹤0.01% 338
2023
Q2
$419K Sell
834
-57
-6% -$27.3K ﹤0.01% 333
2023
Q1
$436K Buy
+891
New +$426K ﹤0.01% 329

Other funds holding IDXX

Empower Advisory Group's IDXX Position: Q1 2026 in Review

Empower Advisory Group reduced its Idexx Laboratories (IDXX) stake by 42% in Q1 2026, selling an estimated $358K and leaving 781 shares worth $439K. The position accounts for ﹤0.01% of the portfolio, ranked #345.

Empower Advisory Group first reported a position in IDXX in Q1 2023 and has held it in 13 quarters since. The position peaked at $907K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Empower Advisory Group held 781 shares of Idexx Laboratories worth $439K as of Q1 2026.
  • Empower Advisory Group sold 559 Idexx Laboratories shares in Q1 2026, an estimated $358K.
  • Idexx Laboratories made up ﹤0.01% of Empower Advisory Group's portfolio in Q1 2026, its #345 holding.
  • Empower Advisory Group first reported a position in Idexx Laboratories in Q1 2023 and has held it in 13 quarters since.
  • Empower Advisory Group's Idexx Laboratories position peaked at $907K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Empower Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.